Geneva, Switzerland – January 12, 2022 – Bebo Health SA, a health and wellness solutions leader, proudly announces its successful listing on the Euronext Access Paris stock exchange. This listing represents a pivotal moment in the company’s growth strategy, providing enhanced visibility and access to capital markets, which are critical for its expansion plans.
- Bebo Health SA gains access to European capital markets to bolster its growth and expansion efforts.
- The Euronext listing enhances Bebo Health’s credibility and visibility among investors and stakeholders.
- The listing gives Bebo Health the financial flexibility to invest in product development and geographic expansion.
Strategic Access to European Capital Markets
The listing on Euronext Access Paris is a significant milestone for Bebo Health SA, offering direct access to the European capital markets. This strategic move enables the company to tap into a broad pool of investors, providing essential capital for scaling operations and launching new initiatives. “Access to these capital markets allows us to accelerate our growth trajectory, invest in cutting-edge health and wellness technologies, and expand our footprint across Europe,” stated Jacques Borgognon, CEO of Bebo Health SA. The listing also positions Bebo Health to leverage the financial resources necessary to drive innovation and maintain its competitive edge in a rapidly evolving industry.
Enhanced Credibility and Investor Confidence
Being listed on Euronext enhances Bebo Health’s credibility and visibility among investors and strengthens its brand reputation. This increased visibility helps attract strategic partnerships and solidifies the company’s standing as a trustworthy and transparent entity in the health and wellness sector. “Our listing on Euronext is a testament to our commitment to transparency and excellence. It signals to our partners and customers that we are serious about our mission to revolutionize health and wellness,” said Jacques Borgognon. The enhanced credibility gained through this listing will be pivotal in attracting new investors and driving the company’s growth ambitions.
Financial Flexibility for Growth and Expansion
The Euronext listing provides Bebo Health with the financial flexibility to support its ambitious growth and expansion plans. The capital raised will be channelled into product development, research and development, and the exploration of new markets across Europe and beyond. “This listing is not just about raising capital; it’s about laying the foundation for sustained growth. We are now better equipped to invest in innovative solutions and enter new geographical markets, ensuring that we continue to meet the evolving needs of our customers,” added Jacques Borgognon. This strategic financial manoeuvre will enable Bebo Health to solidify its market position and drive long-term value for its shareholders.
About Bebo Health SA
Founded in 2019, Bebo Health SA is a Swiss company that distributes innovative health, wellness, and sports products. The company operates through online platforms and physical wellness centres across Europe, offering products that enhance well-being and quality of life.
Contact Information
For media inquiries, please contact:
Bebo Health SA
Media Relations
Phone: +41 22 123 4567
Email: [email protected]
Website: www.bebo-health.com
